This study tested a new COVID-19 vaccine called GEO-CM04S1 in 119 healthy adults. The vaccine uses a modified virus to teach the body to fight SARS-CoV-2. Researchers checked for side effects and measured antibody levels to see if the vaccine works. The trial is now complete.
Phase: PHASE1, PHASE2 • Sponsor: GeoVax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:03 UTC